Canada / Nova Scotia province guide

Peptides in Nova Scotia: check the product and provincial record.

A Nova Scotia-specific peptide guide that connects Health Canada's product and safety records to Nova Scotia Pharmacy Regulator's official route for checking the pharmacy or professional behind an offer.

Market brief

What changes in Nova Scotia.

In Nova Scotia, a Canadian domain, provincial address, clinic page, or local delivery promise does not establish that a peptide product is authorized or that the seller is properly regulated. Nova Scotia Pharmacy Regulator provides the regulator's public practitioner and pharmacy search.

  • Nova Scotia's practitioner and pharmacy lookup helps resolve the local regulated party without turning a matching name into proof of a product, prescription, or delivery route.
  • Health Canada's Drug Product Database is the federal starting point for checking an authorized drug record and its DIN, company, ingredient, dosage form, route, and market status.
  • Peptide Local does not publish a Nova Scotia seller ranking until product category, provincial record, Canadian delivery, exact price, and observation date are sourced together.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Resolve the provincial record

Open find a practitioner or pharmacy and match the legal name, address, record type, and current status behind a pharmacy or professional claim involving Nova Scotia.

02

Check the exact product federally

Search Health Canada's Drug Product Database for the product, active ingredient, company, dosage form, route, status, and eight-digit DIN. A provincial pharmacy record does not create a federal product authorization.

03

Keep the supply category attached

Separate a prescription medicine, pharmacy service, clinic program, compounded preparation, imported parcel, and research-labelled material. Compare an offer only after the product, seller, category, delivery route, price, and date resolve together.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in Nova Scotia?

No blanket answer is supportable. Open find a practitioner or pharmacy and match the legal name, address, record type, and current status behind a pharmacy or professional claim involving Nova Scotia. In Nova Scotia, begin with Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in Nova Scotia?

No. Peptide Local withholds a commercial table for Nova Scotia until seller category, local delivery, regulatory or research status, exact price, and observation date are all sourced. This page is a verification route, not a shopping recommendation.

03

Which official records should I check first in Nova Scotia?

For Nova Scotia, start with Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator, then open Drug Product Database from Health Canada. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and province routes

Tracked peptide names in Nova Scotia.

Each answer preserves the compound’s research, clinical, or medicine identity, connects it to Health Canada’s product database, and then points to the official Nova Scotia pharmacy route. A shared name or provincial record is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in Nova Scotia

KPV in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
02US research-market identity

BPC-157 in Nova Scotia

BPC-157 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
03US research-market identity

TB-500 in Nova Scotia

TB-500 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
04US research-market identity

GHK-Cu in Nova Scotia

GHK-Cu in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
05US research-market identity

Semax in Nova Scotia

Semax in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
06US research-market identity

Melanotan II in Nova Scotia

Melanotan II in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
07US research-market identity

MOTS-c in Nova Scotia

MOTS-c in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Nova Scotia

Tesamorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Nova Scotia

AOD-9604 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
10US research-market identity

Ipamorelin in Nova Scotia

Ipamorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
11US research-market identity

Selank in Nova Scotia

Selank in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Nova Scotia

PT-141 / Bremelanotide in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
13US research-market identity

CJC-1295 no DAC in Nova Scotia

CJC-1295 no DAC in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
14US research-market identity

CJC-1295 DAC in Nova Scotia

CJC-1295 DAC in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
15Investigational clinical program

Retatrutide in Nova Scotia

Retatrutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
16China-approved medicine and active clinical program

Mazdutide in Nova Scotia

Mazdutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
17China-approved medicine and active development program

Ecnoglutide in Nova Scotia

Ecnoglutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
18Investigational clinical program

Enicepatide in Nova Scotia

Enicepatide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
19Investigational clinical program

Eloralintide in Nova Scotia

Eloralintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
20Investigational clinical program

Cagrilintide in Nova Scotia

Cagrilintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
21Investigational clinical program

Petrelintide in Nova Scotia

Petrelintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
22Investigational clinical program

CagriSema in Nova Scotia

CagriSema in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
23Investigational clinical program

MariTide in Nova Scotia

MariTide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
24Investigational clinical program

Survodutide in Nova Scotia

Survodutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
25Investigational clinical program

VK2735 in Nova Scotia

VK2735 in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
26Investigational clinical program

Pemvidutide in Nova Scotia

Pemvidutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
27Investigational clinical program

Amycretin / Zenagamtide in Nova Scotia

Amycretin / Zenagamtide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
28US FDA medicine reference

Tirzepatide in Nova Scotia

Tirzepatide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Nova Scotia

Orforglipron / Foundayo in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Nova Scotia

Semaglutide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Nova Scotia

DSIP / Emideltide in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
32US research-market identity

IGF-1 LR3 in Nova Scotia

IGF-1 LR3 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
33US research-market identity

Kisspeptin-10 / KP-10 in Nova Scotia

Kisspeptin-10 / KP-10 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
34US research-market identity separated from SCENESSE

Melanotan I in Nova Scotia

Melanotan I in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
35US research-market non-peptide coenzyme identity

NAD+ in Nova Scotia

NAD+ in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
36US research-market identity with a withdrawn historical medicine record

Sermorelin in Nova Scotia

Sermorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Nova Scotia

Thymosin Alpha-1 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Nova Scotia

EGRIFTA WR in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
39Product-specific FDA and EU medicine records

Liraglutide in Nova Scotia

Liraglutide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
40Product-specific FDA and EU medicine records

SCENESSE in Nova Scotia

SCENESSE in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
41Product-specific FDA-approved US medicine record

VYLEESI in Nova Scotia

VYLEESI in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.

Official province routeFind a practitioner or pharmacyNova Scotia Pharmacy Regulator
00
Publishing gate

No commercial price table yet.

Peptide Local will not manufacture a ranking from thin data. A local table appears only after seller category, authorization or research status, delivery market, price, and source date can all be stated clearly.

Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides